Shirley Hollander

No open positions remaining

Net worth: 467 065 $ as of 2026-05-30

41 year

Consumer Services

Commercial Services

Profile

Shirley Winkler Hollander is Chief Financial Officer & Executive Director at iFOREX Financial Trading Holdings Ltd. starting in 2025.
Former roles include Finance Director at Stk Bio-Ag Technologies from 2021 to 2024, Associate Director-Accounting at Teva Pharmaceuticals Ltd. (Israel) from 2017 to 2021, and Assurance Manager at Ernst & Young (Israel) Ltd. from 2010 to 2017.
Education includes an undergraduate degree from Ben-Gurion University of the Negev.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.78%	2026-03-15	175,000 ( 0.78% )	467 065 $	2026-05-30

Shirley Hollander active positions

Companies	Position	Start

All active positions of Shirley Hollander

Former positions of Shirley Hollander

Companies	Position	End
Stk Bio-Ag Technologies	Director of Finance/CFO	2024-06-30
Teva Pharmaceuticals Ltd. (Israel)	Comptroller/Controller/Auditor	2021-05-31
Ernst & Young (Israel) Ltd. Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services	Corporate Officer/Principal	2017-08-31

See the detail of Shirley Hollander's experience

Training of Shirley Hollander

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shirley Hollander's experience

Linked companies

Private companies	4
Ben-Gurion University of the Negev Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ernst & Young (Israel) Ltd. Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services	Commercial Services
Stk Bio-Ag Technologies
Teva Pharmaceuticals Ltd. (Israel)